Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
0.7811
-0.0239 (-2.97%)
At close: Mar 28, 2025, 4:00 PM
0.7877
+0.0065 (0.84%)
After-hours: Mar 28, 2025, 7:55 PM EDT
Affimed Market Cap
Affimed has a market cap or net worth of $12.80 million as of March 28, 2025. Its market cap has decreased by -82.09% in one year.
Market Cap
12.80M
Enterprise Value
300.16K
1-Year Change
-82.09%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since September 12, 2014, Affimed's market cap has decreased from $126.70M to $12.80M, a decrease of -89.89%. That is a compound annual growth rate of -19.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 12.80M | -34.36% |
| Dec 31, 2024 | 19.50M | -79.10% |
| Dec 29, 2023 | 93.30M | -49.62% |
| Dec 30, 2022 | 185.20M | -65.86% |
| Dec 31, 2021 | 542.50M | 22.24% |
| Dec 31, 2020 | 443.80M | 159.38% |
| Dec 31, 2019 | 171.10M | 17.59% |
| Dec 31, 2018 | 145.50M | 236.81% |
| Dec 29, 2017 | 43.20M | -27.88% |
| Dec 30, 2016 | 59.90M | -64.93% |
| Dec 31, 2015 | 170.80M | 23.86% |
| Dec 31, 2014 | 137.90M | 8.84% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |